Cancer patients at risk of herb/food supplement-drug interactions: A systematic review

Phytotherapy Research

Volumn 28, Issue 12, 2014, Pages 1749-1755

  Alsanad, Saud M ^a   Williamson, Elizabeth M ^a   Howard, Rachel L ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

Cancer patient; Complementary and alternative medicine (CAM); Drug interaction; Food supplement; Herbal medicine; Systematic review

Indexed keywords

ACETYLSALICYLIC ACID; BENDROFLUMETHIAZIDE; CALCIUM; CISPLATIN; COD LIVER OIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FISH OIL; GERMANIUM; GLIBENCLAMIDE; IRINOTECAN; IRON; KAVA; MAGNESIUM; MULTIVITAMIN; NAVELBINE; OMEPRAZOLE; PACLITAXEL; POTASSIUM; RITUXIMAB; TRASTUZUMAB; UBIDECARENONE; UNINDEXED DRUG; VALERIAN; VINCRISTINE; WARFARIN;

AGARICUS; ALOE VERA; ALTERNATIVE MEDICINE; APRICOT; CANCER PATIENT; CHINESE HERB; DIET SUPPLEMENTATION; ECHINACEA; EVENING PRIMROSE; FOOD DRUG INTERACTION; GARLIC; GINGER; GINKGO BILOBA; GINSENG; HERB DRUG INTERACTION; HERBAL MEDICINE; HERBAL TEA; HIGH RISK PATIENT; HUMAN; HYDRASTIS; HYPERICUM PERFORATUM; MEDICINAL MUSHROOM; PARSLEY; REVIEW; RHODIOLA; RISK ASSESSMENT; SILYBUM MARIANUM; SOYBEAN; SYSTEMATIC REVIEW; TEA; VISCUM ALBUM; YAM;

EID: 85027945203     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5213     Document Type: Review

References (20)

1. Abebe W. 2002. Herbal medication: potential for adverse interactions with analgesic drugs. J Clin Pharm Ther 2:391-401.
2. Bishop FL, Prescott P, Chan YK, Saville J, Von Elm E, Lewith G. 2010. Prevalence of complementary medicine use in pediatric cancer: a systematic review. Pediatrics 125:768-776.
3. Chiu I, Brennan M. 1990. The effectiveness of some techniques for improving mail survey response rates: a meta-analysis. Market Bull 1:1-7.
4. Corner J, Yardley J, Maher EJ, et al. 2009. Patterns of complementary and alternative medicine use among patients undergoing cancer treatment. Eur J Cancer Care 18(3):271-279
5. Cramer H, Cohen L, Dobos G, Witt CM. 2013. Integrative oncology: best of both worlds-theoretical, practical, and research issues. Evid Based Complement Altern Med 2013:383142.
6. Dergal MJ, Gold JL, Laxer DA, et al. 2002. Potential interactions between herbal medicines and conventional drug therapies used by older adults attending a memory clinic. Drugs Aging 19:879-886.
7. Engdal S, Klepp O, Nilsen OG. 2009. Identification and exploration of herb-drug combinations used by cancer patients. Integr Cancer Ther 8:29-36.
8. Ernst E. 1998. The prevalence of complementary/alternative medicine in cancer. Cancer 83:777-782.
9. Goey AK, Mooiman KD, Beijnen JH, Schellens JH, Meijerman I. 2013. Relevance of in vitro and clinical data for predicting CYP3A4-mediated herb-drug interactions in cancer patients. Cancer Treat Rev 39(7):773-783.
10. Goey AK, Beijnen JH, Schellens JH. 2014. Herb-drug interactions in oncology. Clin Pharmacol Ther 95(4):354-355.
11. Izzo A. 2012. Interactions between herbs and conventional drugs: overview of the clinical data. Med Princ Pract 21(5):404-428.
12. Klepser TB, Klepser ME. 1999. Unsafe and potentially safe herbal therapies. Am J Health Syst Pharm 56:125-138.
13. Lee AH, Ingraham SE, Kopp M, et al. 2006. The incidence of potential interactions between dietary supplements and prescription medications in cancer patients at a Veterans Administration Hospital. Am J Clin Oncol 29:178-182.
14. McCune JS, Hatfield AJ, Blackburn AA, et al. 2004. Potential of chemotherapy-herb interactions in adult cancer patients. Support Care Cancer 12:454-462.
15. Mclay J, Stewart D, George J, et al. 2012. Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions? Eur J Clin Pharmacol 68:811-819.
16. Russo E, Scicchitano F, Whalley BJ, et al. 2014. Hypericum perforatum: pharmacokinetic, mechanism of action, tolerability, and clinical drug-drug interactions. Phytother Res 28(5):643-655.
17. Thomsen M, Schmidt M, Vitetta L, Sali A. 2005. Do herbs increase the risk of herb-drug interactions for patients with arthritis? Ann Rheum Dis 64:1527-1528.
18. Werneke U, Earl J, Seyedl C, et al. 2004. Potential health risks of complementary alternative medicines in cancer patients. Br J Cancer 90:408-413.
19. Williamson EM, Driver SB, Baxter K, Lee CR. 2013. Stockley's Herbal Medicines Interactions: A Guide to the Interactions of Herbal Medicines, 2nd edn. Pharmaceutical Press: London, UK.
20. Zeller T, Muenstedt K, Stoll C, et al. 2013. Potential interactions of complementary and alternative medicine with cancer therapy in outpatients with gynecological cancer in a comprehensive cancer center. J Cancer Res Clin Oncol 139:357-365.